. . . . . "clinical trial"@en . "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder"@en . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . . . "Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder"@nl . "Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)"@en . "Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder"@nl . . "2018-09-01T00:00:00Z"^^ . "Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)"@en . . . . "ensayu cl\u00EDnicu"@ast . "207"^^ . "Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder"@nl . . . . . "Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)"@en . . . "18"^^ . "klinisch onderzoek"@nl . . "NCT03018340" . "2016-12-01T00:00:00Z"^^ . . .